Measurement of liver fat content using selective saturation at 3.0 T

被引:27
作者
Cotler, Scott J.
Guzman, Grace
Layden-Almer, Jennifer
Mazzone, Theodore
Layden, Thomas J.
Zhou, Xiaohong Joe
机构
[1] Univ Illinois, Sec Hepatol, Chicago, IL USA
[2] Univ Illinois, Dept Pathol, Chicago, IL USA
[3] Univ Illinois, Sect Diabet & Metab, Chicago, IL USA
[4] Univ Illinois, Dept Neurosurg, Chicago, IL USA
[5] Univ Illinois, Dept Radiol, Chicago, IL USA
[6] Univ Illinois, Dept Bioengn, Chicago, IL USA
[7] Univ Illinois, Magnet Resonance Res Ctr, Chicago, IL USA
关键词
nonalcoholic fatty liver disease; liver phantoms; selective saturation; water-fat imaging; 3.0 T scanner;
D O I
10.1002/jmri.20865
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To validate an MRI technique for measuring liver fat content by calibrating MRI readings with liver phantoms and comparing MRI measurements in human subjects with estimates of liver fat content on liver biopsy specimens. Materials and Methods: The MRI protocol consisted of fat and water imaging by selective saturation using a 3.0-T scanner. A water phantom and liver phantoms were scanned before each of 10 human subjects who under-went a liver biopsy to assess for nonalcoholic fatty liver disease (NAFLD). Liver fat content in human subjects was derived from a calibration curve generated by scanning the phantoms. Liver fat was also estimated by optical image analysis and pathologists' assessment of histologic sections. Results: MRI measurements of the liver phantoms were highly reproducible. Measurements of liver fat content in human subjects made by MRI in two areas of the liver were strongly correlated (r = 0.98, P < 0.001). MRI measurements were highly associated with estimates of liver fat content made by optical image analysis (r = 0.96, P < 0.001) and with estimates made by the pathologists (r 0.93, P < 0.001). Conclusion: We validated a technique for quantifying liver fat content based on selective fat and water imaging. The technique is accurate and reproducible and provides a noninvasive method to obtain serial measurements of liver fat content in human subjects.
引用
收藏
页码:743 / 748
页数:6
相关论文
共 15 条
[1]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[2]   Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes [J].
Bajaj, M ;
Suraamornkul, S ;
Pratipanawatr, T ;
Hardies, LJ ;
Pratipanawatr, W ;
Glass, L ;
Cersosimo, E ;
Miyazaki, Y ;
DeFronzo, RA .
DIABETES, 2003, 52 (06) :1364-1370
[3]   Intensity non-uniformity correction in MRI: Existing methods and their validation [J].
Belaroussi, B ;
Milles, J ;
Carme, S ;
Zhu, YM ;
Benoit-Cattin, H .
MEDICAL IMAGE ANALYSIS, 2006, 10 (02) :234-246
[4]   Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[5]   Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions [J].
Brunt, EM ;
Janney, CG ;
Di Bisceglie, AM ;
Neuschwander-Tetri, BA ;
Bacon, BR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) :2467-2474
[6]   SIMPLE PROTON SPECTROSCOPIC IMAGING [J].
DIXON, WT .
RADIOLOGY, 1984, 153 (01) :189-194
[7]   Introduction of fast MR imaging in the assessment of hepatic steatosis [J].
Fishbein, MH ;
Gardner, KG ;
Potter, CJ ;
Schmalbrock, P ;
Smith, MA .
MAGNETIC RESONANCE IMAGING, 1997, 15 (03) :287-293
[8]   Rapid MRI using a modified Dixon technique: a non-invasive and effective method for detection and monitoring of fatty metamorphosis of the liver [J].
Fishbein, MH ;
Stevens, WR .
PEDIATRIC RADIOLOGY, 2001, 31 (11) :806-809
[9]   Design and validation of a histological scoring system for nonalcoholic fatty liver disease [J].
Kleiner, DE ;
Brunt, EM ;
Van Natta, M ;
Behling, C ;
Contos, MJ ;
Cummings, OW ;
Ferrell, LD ;
Liu, YC ;
Torbenson, MS ;
Unalp-Arida, A ;
Yeh, M ;
McCullough, AJ ;
Sanyal, AJ .
HEPATOLOGY, 2005, 41 (06) :1313-1321
[10]   Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome [J].
Marchesini, G ;
Bugianesi, E ;
Forlani, G ;
Cerrelli, F ;
Lenzi, M ;
Manini, R ;
Natale, S ;
Vanni, E ;
Villanova, N ;
Melchionda, N ;
Rizzetto, M .
HEPATOLOGY, 2003, 37 (04) :917-923